If you've found yourself dashing to the loo more often than normal, it might not just be down to one too many cuppas. It ...

India pivots from generics to biologics with Biopharma Shakti, a major Budget 2026 push to expand R&D, clinical trials and ...

The United States has introduced a new food pyramid with significantly more meat, dairy and fat. Health and sustainability experts are alarmed.

The Union Budget 2026-27 exempts customs duty on 17 essential cancer drugs and medicines for seven rare diseases, making treatments more affordable. Learn how these changes can reduce your medical ...

Budget 2026’s Biopharma Shakti aims to tackle top non-communicable diseases like diabetes, cancer, and autoimmune diseases by investing Rs. 10,000 crores into biopharma capabilities, aiming to reduce ...

In her Budget 2026-27 presentation to Parliament today, Finance Minister Nirmala Sitharaman announced the launch of Biopharma Shakti, a dedicated initiative aimed at positioning India as a global ...

Union Budget 2026 unveiled a Rs 10,000 crore Biopharma Shakti mission to boost advanced medicine production, tackle rising diabetes and obesity, and strengthen India’s fight against non-communicable ...

As non-communicable diseases overtake infections, the Shakti scheme aims to build a globally competitive ecosystem for ...

Finance Minister Nirmala Sitharaman announces Biopharma Shakti, a ₹10,000 crore plan to boost biologics, biosimilars, clinical trials and regulatory capacity in India.

Nirmala Sitharaman said that the government will provide timely access to high-quality assistive devices for all eligible ...

The country has made significant improvements in increasing access to healthcare by providing better and more affordable ...